​

Creative Medical Technology Stock (NASDAQ:CELZ)

RevenueOwnershipFinancialsChart

Previous Close

$2.30

52W Range

$1.50 - $6.25

50D Avg

$2.00

200D Avg

$2.63

Market Cap

$5.88M

Avg Vol (3M)

$42.46K

Beta

1.99

Div Yield

-

CELZ Company Profile

Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

4

IPO Date

Nov 06, 2015

Website

CELZ Performance

CELZ Financial Summary

Dec 25Dec 24Dec 23
Revenue$6.00K$11.00K$9.00K
Operating Income$-6.02M$-5.74M$-5.62M
Net Income$-6.00M$-5.49M$-5.29M
EBITDA$-6.02M$-5.63M$-5.53M
Basic EPS$-2.52$-3.71$-3.76
Diluted EPS$-2.52$-3.71$-3.76

Fiscal year ends in Dec 25 | Currency in USD

Peer Comparison

TickerCompany
ALZNAlzamend Neuro, Inc.
HCWBHCW Biologics Inc.
ADXNAddex Therapeutics Ltd
ACXPAcurx Pharmaceuticals, Inc.
ADILAdial Pharmaceuticals, Inc.
KPRXKiora Pharmaceuticals, Inc.
PHIOPhio Pharmaceuticals Corp.
APREAprea Therapeutics, Inc.
BCDABioCardia, Inc.
CDIOCardio Diagnostics Holdings, Inc.